InsiderTrades

Form 4 for WST West Pharmaceutical Services

Accepted 2026-05-14 16:00:32 ET · period of report 2026-05-12 · accession 0000105770-26-000075 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-05-14 16:00 2026-05-12 WST Campbell Shane Alden SVP, Proprietary Segment M - OptEx — +769.59 747.72 New —
DM 2026-05-14 16:00 2026-05-12 WST Campbell Shane Alden SVP, Proprietary Segment F - Tax $312.07 -219.26 612.80 -26% -$68.4K
DM 2026-05-14 16:00 2026-05-12 WST Campbell Shane Alden SVP, Proprietary Segment M - OptEx $0.00 -769.59 1,417 -35% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-05-12 M A 296.00 — 358.46 D — — (F1) Restricted stock units convert into common stock on a one-for-one basis.
2 Common Common Stock 2026-05-12 F D 84.33 $312.07 274.13 D — —
3 Common Common Stock 2026-05-12 M A 473.59 — 747.72 D — — (F1) Restricted stock units convert into common stock on a one-for-one basis.
4 Common Common Stock 2026-05-12 F D 134.93 $312.07 612.80 D — —
5 Derivative Rst. Stock Unit 2026-05-12 M D 296.00 $0.00 886.00 D — · — to — 296.00 Common Stock (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) On May 12, 2025, the reporting person was granted 1,182 restricted stock units, vesting in four equal annual installments (plus dividend equivalents). (F2) On May 12, 2025, the reporting person was granted 1,182 restricted stock units, vesting in four equal annual installments (plus dividend equivalents).
6 Derivative Rst. Stock Unit 2026-05-12 M D 473.59 $0.00 1,417.41 D — · — to — 473.59 Common Stock (F1) Restricted stock units convert into common stock on a one-for-one basis. (F3) On May 12, 2025, the reporting person was granted 1,891 restricted stock units, vesting in four equal annual installments (plus dividend equivalents). (F3) On May 12, 2025, the reporting person was granted 1,891 restricted stock units, vesting in four equal annual installments (plus dividend equivalents).